NO944689L - Imidazopyrider - Google Patents

Imidazopyrider

Info

Publication number
NO944689L
NO944689L NO944689A NO944689A NO944689L NO 944689 L NO944689 L NO 944689L NO 944689 A NO944689 A NO 944689A NO 944689 A NO944689 A NO 944689A NO 944689 L NO944689 L NO 944689L
Authority
NO
Norway
Prior art keywords
imidazopyrider
nistic
char1
aldosteronism
properties
Prior art date
Application number
NO944689A
Other languages
English (en)
Norwegian (no)
Other versions
NO944689D0 (no
Inventor
Werner Mederski
Dieter Dorsch
Mathias Osswald
Norbert Beier
Pierre Schelling
Klaus-Otto Minck
Ingeborg Lues
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO944689D0 publication Critical patent/NO944689D0/no
Publication of NO944689L publication Critical patent/NO944689L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO944689A 1993-12-06 1994-12-05 Imidazopyrider NO944689L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4341453A DE4341453A1 (de) 1993-12-06 1993-12-06 Imidazopyridine

Publications (2)

Publication Number Publication Date
NO944689D0 NO944689D0 (no) 1994-12-05
NO944689L true NO944689L (no) 1995-06-07

Family

ID=6504241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944689A NO944689L (no) 1993-12-06 1994-12-05 Imidazopyrider

Country Status (16)

Country Link
US (1) US5532276A (Direct)
EP (1) EP0657452A1 (Direct)
JP (1) JPH07196656A (Direct)
KR (1) KR950018006A (Direct)
CN (1) CN1109056A (Direct)
AU (1) AU7919094A (Direct)
CA (1) CA2137213A1 (Direct)
CZ (1) CZ304694A3 (Direct)
DE (1) DE4341453A1 (Direct)
HU (1) HUT72595A (Direct)
NO (1) NO944689L (Direct)
PL (1) PL306127A1 (Direct)
RU (1) RU94042907A (Direct)
SK (1) SK149294A3 (Direct)
TW (1) TW294665B (Direct)
ZA (1) ZA949664B (Direct)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798364A (en) * 1992-03-26 1998-08-25 Merck Patent Gesellschaft Mit Beschrankter Haftung Imidazopyridines
US6348380B1 (en) * 2000-08-25 2002-02-19 Micron Technology, Inc. Use of dilute steam ambient for improvement of flash devices
EP1490064B1 (en) * 2002-02-14 2009-11-18 Pharmacia Corporation Substituted pyridinones as modulators of p38 map kinase
AU2003253387A1 (en) * 2002-08-07 2004-02-25 Novartis Ag Organic compounds as agents for the treatment of aldosterone mediated conditions
US7550590B2 (en) 2003-03-25 2009-06-23 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1625122A1 (en) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
ZA200602051B (en) 2003-08-13 2007-10-31 Takeda Pharmaceutical 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1699777B1 (en) 2003-09-08 2012-12-12 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
BRPI0418639B8 (pt) 2004-03-15 2021-05-25 Takeda Pharmaceutical compostos inibidores de dipeptidil peptidase, assim como composição farmacêutica contendo os mesmos
US7687638B2 (en) 2004-06-04 2010-03-30 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
AU2005277137A1 (en) * 2004-08-23 2006-03-02 Wyeth Pyrrolo-naphthyl acids as PAI-1 inhibitors
CA2577846A1 (en) 2004-08-23 2006-03-02 Wyeth Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
JP2008510815A (ja) 2004-08-23 2008-04-10 ワイス 血栓症および心臓血管疾患の治療にて有用な調節剤であるプラスミノゲン活性化因子阻害剤１型（ｐａｉ−１）としてのオキサゾロ−ナフチル酸
WO2006068978A2 (en) 2004-12-21 2006-06-29 Takeda Pharmaceutial Company Limited Dipeptidyl peptidase inhibitors
ZA200802857B (en) 2005-09-14 2009-09-30 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
CN101360723A (zh) 2005-09-16 2009-02-04 武田药品工业株式会社 制备嘧啶二酮衍生物的方法
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
WO2009123241A1 (ja) * 2008-03-31 2009-10-08 株式会社レナサイエンス プラスミノーゲンアクチベーターインヒビター－１阻害剤
EP2607348B8 (en) * 2009-03-31 2021-04-21 Renascience Inc. Plasminogen Activator Inhibitor-1 Inhibitor
JP5840324B2 (ja) 2013-04-15 2016-01-06 株式会社レナサイエンス Ｐａｉ−１阻害剤の新規用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
DE4110019C2 (de) * 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
US5332750A (en) * 1991-09-04 1994-07-26 Merck Patent Gesellschaft Mit Beschrankter Haftung 1,2-dihydro-2-oxopyridines
DE4141788A1 (de) * 1991-12-18 1993-06-24 Merck Patent Gmbh Imidazopyridine
DE4208304A1 (de) * 1992-03-16 1993-09-23 Merck Patent Gmbh 2-oxochinolinderivate
DE4211474A1 (de) * 1992-04-06 1993-10-07 Merck Patent Gmbh Imidazopyridine
DE4305602A1 (de) * 1992-06-17 1993-12-23 Merck Patent Gmbh Imidazopyridine
DE4225835A1 (de) * 1992-08-05 1994-02-10 Merck Patent Gmbh Verfahren zur Herstellung von Imidazopyridinen
DE4242459A1 (de) * 1992-12-16 1994-06-23 Merck Patent Gmbh Imidazopyridine

Also Published As

Publication number Publication date
CN1109056A (zh) 1995-09-27
US5532276A (en) 1996-07-02
PL306127A1 (en) 1995-06-12
ZA949664B (en) 1995-08-15
RU94042907A (ru) 1996-10-20
CA2137213A1 (en) 1995-06-07
HU9403451D0 (en) 1995-02-28
SK149294A3 (en) 1995-07-11
CZ304694A3 (en) 1995-08-16
EP0657452A1 (de) 1995-06-14
JPH07196656A (ja) 1995-08-01
DE4341453A1 (de) 1995-06-08
HUT72595A (en) 1996-05-28
TW294665B (Direct) 1997-01-01
NO944689D0 (no) 1994-12-05
AU7919094A (en) 1995-06-15
KR950018006A (ko) 1995-07-22

Similar Documents

Publication Publication Date Title
NO944689L (no) Imidazopyrider
NO942095L (no) Imidazopyridiner
ATE177099T1 (de) Diazabicyclische neurokinin antagonisten
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
AU7562496A (en) Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids
MY121967A (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
NO20002702L (no) Tienopyrimidiner
ATE194593T1 (de) 3-(3,4-dioxyphenyl)-pyrrolidine als inhibitonen der typ iv - phosphodiesterase zur behandlung von entzündungskrankheiten
NO178262C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksanoler
DE69411424D1 (de) Zur Behandlung von Erkrankungen des Zentralnervensystems verwendbare Benzimidazole
DE60027769D1 (de) Pyrrolidin-derivate als inhibitoren von cyclischer amp-phosphodiesterase
NO973338L (no) N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse
ATE224718T1 (de) Verwendung eines k-252a derivats zur behandlung von periphärer oder zentraler nervenerkrankungen und übermässiger cytokinbildung
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
FI113767B (fi) Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa
NO20021083L (no) Pyrazolo[4,3-d]pyrimidiner
RU94039284A (ru) Производные пиперазина, способ их получения, фармкомпозиция и ее использование
NO176097C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksener
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
MX9306563A (es) Derivados de imidazopiridinas, proceso para su preparacion y formulaciones farmaceuticas que los contienen.
EP0300088A3 (en) 1,5-benzoxathiepin derivatives, their production and use
NO20021310L (no) Aminderivater
RU93048331A (ru) Имидазопиридины, способ их получения, фармацевтическая композиция и способ ее получения, способ лечения
RU93004969A (ru) Новые производные бензимидазола
RU93048867A (ru) Ди-, соответственно, триазиндионы, способ их получения, фармацевтическая композиция, способ ее получения и способ лечения